A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.

Liverpool Hospital, Liverpool

Sint Augustinus Wilrijk, Wilrijk

Antwerp University Hospital, Edegem

Peter MacCallum Cancer Centre, Melbourne

Alfred Hospital, Melbourne

The Queen Elizabeth Hospital, Woodville South

St. John of God - Subiaco Hospital, Subiaco

Universitatsklinikum Eppendorf, Hamburg

Elbe Kliniken Stade-Buxtehude GmbH, Buxtehude

University of Virginia, Charlottesville

Uni Schleswig-Holstein, Lübeck

Hospital General Universitario Gregorio Marañon, Madrid

Atlanta Cancer Care, Alpharetta

Clinica Universidad de Navarra, Pamplona

Cancer Specialists, Jacksonville

Moffitt McKinley Outpatient Center, Tampa

Sarah Cannon Research Institute / Tennessee Oncology, Nashville

Hospital Universitario Virgen Macarena, Seville

Fachklinik Hornheide, Münster

Universitätsklinikum Koeln, Cologne

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Hautklinik und Poliklinik, Mainz

Northwestern University, Chicago

Washington University, St Louis

Med. Fakultat Mannheim der Universitat Heidelberg, Mannheim

Universitätsklinikum Heidelberg, Heidelberg

Universitätshautk. Tübingen, Tübingen

University of Colorado, Denver

Intermountain Surgical Oncology, Murray

Huntsman Cancer Institute, Salt Lake City

City of Hope Comprehensive Cancer Center, Duarte

University of California San Diego Moores Cancer Center, La Jolla

UCSF Comprehensive Cancer Ctr, San Francisco

Oregon Health and Science University, Portland

Seattle Cancer Care Alliance, Seattle

Hospital Universitario La Paz, Madrid

Massachusetts General Hospital., Boston

Case Western Research University, Cleveland

Instituto Oncológico Dr. Rosell, Barcelona

Vall d?Hebron Institute of Oncology (VHIO), Barcelona, Barcelona

Hospital Clinic de Barcelona, Barcelona

Barts and The London, London